Crispr Therapeutics shares tumble after significant earnings miss
LONDON - Merit Group Plc (AIM: MRIT), a data and intelligence business, has announced the approval of all resolutions during its General Meeting held today, leading to the cancellation of its shares from trading on the AIM market. The company’s shareholders voted in favor of two special resolutions with approximately 79.01% of votes supporting the motions.
The resolutions, detailed in a circular on January 30, 2025, and available on the company’s website, received 16,826,467 votes for and 4,469,642 votes against, excluding withheld votes which do not count in the legal calculation of vote proportions.
Following this shareholder approval, Merit Group’s ordinary shares are scheduled to be delisted from AIM effective 7:00 a.m. on March 5, 2025. Consequently, the final day for trading the company’s ordinary shares on AIM will be March 4, 2025.
This move comes after careful consideration and is part of the company’s strategic efforts. The implications of this decision for investors and the company’s future operations have not been disclosed in the press release statement.
The announcement, which is now in the public domain, was made in accordance with the UK version of the Market Abuse Regulation No 596/2014, as part of English Law through the European (Withdrawal) Act 2018, as amended.
Shareholders and interested parties can find further details on the Merit Group’s website. The announcement is based on a press release statement from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.